Showing 7631-7640 of 8836 results for "".
- Meet JOULE X and More New Offerings from Sciton at ASLMShttps://practicaldermatology.com/news/meet-joule-x-and-more-new-offerings-from-sciton-at-aslms/2459954/Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the company’s latest multi-device platform. It work
- BTL to Launch Small Emsculpt Applicator for Arms, Thighs, Calveshttps://practicaldermatology.com/news/btl-to-launch-small-emsculpt-applicator-for-arms-thighs-calves/2459955/BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and buttocks. In addition to launching the small appl
- Allergan Acquires Envy Medical, Inc.https://practicaldermatology.com/news/allergan-acquires-envy-medical-inc/2459957/Allergan now owns Envy Medical, Inc. The acquisition adds Envy's Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body, to Allergan's portfolio. Offered in physician's offices, medical spas and l
- Biofrontera Acquires Cutanea Life Scienceshttps://practicaldermatology.com/news/biofrontera-acquires-cutanea-life-sciences/2459959/Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller. Maruho holds approximately 20 percent of Biofrontera AG. Cutanea is a US-based phar
- Jean Bolognia, MD Honored with AAD Gold Medalhttps://practicaldermatology.com/news/jean-bolognia-md-honored-with-aad-gold-medal/2459966/During the 2019 Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C., the AAD awarded Jean Bolognia, MD, Professor of Dermatology at the Yale University School of Medicine, with its Gol
- Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc.https://practicaldermatology.com/news/constellation-alpha-capital-corp-signs-letter-of-intent-to-acquire-dermtech-inc/2459970/Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. DermTech markets and develops products that facilitate the early detection of skin
- History of Dermatology Society Names Samuel J. Zakon Awardeehttps://practicaldermatology.com/news/history-of-dermatology-society-names-samuel-j-zakon-awardee/2459972/Frederick C. Gaede, BA, MAS, has received the Samuel J. Zakon Award in the History of Dermatology for his article entitled “Henry Granger Piffard, MD and His Photogenic Pistol Cartridges.” The Award was announced at the forty-sixth annual meeting of the History of Dermatology Society
- FDA Approves Dupixent for Moderate to Severe AD in Adolescentshttps://practicaldermatology.com/news/us-fda-approves-dupixent-for-moderate-to-severe-atopic-dermatitis-in-adolescents/2459975/The FDA has approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA's eczema drug Dupixent to include patients aged 12 through 17 whose disease is not adequately controlled with topical prescription
- 2019 NewBeauty Awards: Alastin's TransFORM Body Treatment Acknowledged for Innovationhttps://practicaldermatology.com/news/2019-newbeauty-awards-alastins-transform-body-treatment-acknowledged-for-innovation/2459977/ALASTIN Skincare, Inc’s TransFORM Body Treatment has been awarded a 2019 NewBeauty Award in the innovations category. NewBeauty acknowledges the best products, treatments and trends in cosmetics and aesthetics with their innovation category described as, "the future is now
- Biopelle Launches Emepelle to Address Estrogen Deficient Skinhttps://practicaldermatology.com/news/biopelle-launches-emepelle-to-address-estrogen-deficient-skin/2459979/Biopelle, Inc. has launched Emepelle, the first and only clinically proven skincare line that safely and effectively helps address Estrogen Deficient Skin (EDS). Emepelle features MEP Technology, a patented, specifically designed ingredient that helps